Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Clinical manifestations, diagnosis, and treatment of extrapulmonary and miliary tuberculosis

INTRODUCTION

Miliary tuberculosis (TB) refers to clinical disease resulting from the hematogenous dissemination of Mycobacterium tuberculosis. The term miliary was coined in 1700 by John Jacobus Manget, who likened the appearance of the involved lung, with its surface covered with firm small white nodules, to millet seeds (picture 1). Originally a pathologic and then a radiographic description, the term miliary TB is now used to denote all forms of progressive, widely disseminated hematogenous TB. Miliary TB can arise as a result of progressive primary infection or via reactivation of a latent focus with subsequent spread.

The clinical manifestations, diagnosis, treatment, and prevention of miliary TB will be reviewed here. The pathogenesis and epidemiology of miliary TB are discussed separately. (See "Epidemiology and pathology of extrapulmonary and miliary tuberculosis".)

CLINICAL MANIFESTATIONS

Several large retrospective series provide much of the data on the clinical features of miliary tuberculosis (TB) (table 1) [1-6]. While these studies include a relatively large number of patients, they differ markedly by year, inclusion criteria, country, and type of medical center, so direct comparison is difficult.

The clinical presentation of miliary TB is highly variable; manifestations can be acute but are more likely to be subacute or chronic. In highly endemic areas, miliary TB may be associated with reinfection. Development of miliary TB during primary infection can present with relatively acute onset and rapid clinical course. Acute disease may be fulminant, including multiorgan system failure [7], a syndrome of septic shock [8], and acute respiratory distress syndrome (ARDS) [9,10].

The subacute or chronic presentations of miliary TB are more common than acute disease. These patients may present with failure to thrive [5], fever of unknown origin [2], or dysfunction of one or more organ systems [11]. The most common extrapulmonary sites of disease include the lymphatic system, bones and joints, and the liver. Night sweats are frequent. Rigors are unusual but have been described [12,13]. In one series including 38 patients, the median duration of illness was two months [2]. Symptoms and signs of miliary TB are described in the Tables (table 2 and table 3).

                            

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Jul 2014. | This topic last updated: Jul 3, 2014.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Maartens G, Willcox PA, Benatar SR. Miliary tuberculosis: rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults. Am J Med 1990; 89:291.
  2. Kim JH, Langston AA, Gallis HA. Miliary tuberculosis: epidemiology, clinical manifestations, diagnosis, and outcome. Rev Infect Dis 1990; 12:583.
  3. Gelb AF, Leffler C, Brewin A, et al. Miliary tuberculosis. Am Rev Respir Dis 1973; 108:1327.
  4. Munt PW. Miliary tuberculosis in the chemotherapy era: with a clinical review in 69 American adults. Medicine (Baltimore) 1972; 51:139.
  5. Proudfoot AT, Akhtar AJ, Douglas AC, Horne NW. Miliary tuberculosis in adults. Br Med J 1969; 2:273.
  6. BIEHL JP. Miliary tuberculosis; a review of sixty-eight adult patients admitted to a municipal general hospital. Am Rev Tuberc 1958; 77:605.
  7. Sydow M, Schauer A, Crozier TA, Burchardi H. Multiple organ failure in generalized disseminated tuberculosis. Respir Med 1992; 86:517.
  8. Ahuja SS, Ahuja SK, Phelps KR, et al. Hemodynamic confirmation of septic shock in disseminated tuberculosis. Crit Care Med 1992; 20:901.
  9. Piqueras AR, Marruecos L, Artigas A, Rodriguez C. Miliary tuberculosis and adult respiratory distress syndrome. Intensive Care Med 1987; 13:175.
  10. Mohan A, Sharma SK, Pande JN. Acute respiratory distress syndrome (ARDS) in miliary tuberculosis: a twelve year experience. Indian J Chest Dis Allied Sci 1996; 38:157.
  11. Asada Y, Hayashi T, Sumiyoshi A, et al. Miliary tuberculosis presenting as fever and jaundice with hepatic failure. Hum Pathol 1991; 22:92.
  12. Harvey C, Eykyn S, Davidson C. Rigors in tuberculosis. Postgrad Med J 1993; 69:724.
  13. Lowry KJ, Stephan KT, Davis CE. Miliary tuberculosis presenting with rigors and developing unusual cutaneous manifestations. Cutis 1999; 64:23.
  14. Rieder HL, Kelly GD, Bloch AB, et al. Tuberculosis diagnosed at death in the United States. Chest 1991; 100:678.
  15. Ansari NA, Kombe AH, Kenyon TA, et al. Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998. Int J Tuberc Lung Dis 2002; 6:55.
  16. Heap MJ, Bion JF, Hunter KR. Miliary tuberculosis and the adult respiratory distress syndrome. Respir Med 1989; 83:153.
  17. Lintin SN, Isaac PA. Miliary tuberculosis presenting as adult respiratory distress syndrome. Intensive Care Med 1988; 14:672.
  18. Murray HW, Tuazon CU, Kirmani N, Sheagren JN. The adult respiratory distress syndrome associated with miliary tuberculosis. Chest 1978; 73:37.
  19. Dyer RA, Chappell WA, Potgieter PD. Adult respiratory distress syndrome associated with miliary tuberculosis. Crit Care Med 1985; 13:12.
  20. Heffner JE, Strange C, Sahn SA. The impact of respiratory failure on the diagnosis of tuberculosis. Arch Intern Med 1988; 148:1103.
  21. Corbella X, Carratala J, Rufi G, Gudiol F. Unusual manifestations of miliary tuberculosis: cutaneous lesions, phalanx osteomyelitis, and paradoxical expansion of tenosynovitis. Clin Infect Dis 1993; 16:179.
  22. Teo HE, Peh WC. Skeletal tuberculosis in children. Pediatr Radiol 2004; 34:853.
  23. Vohra R, Kang HS, Dogra S, et al. Tuberculous osteomyelitis. J Bone Joint Surg Br 1997; 79:562.
  24. Brusko G, Melvin WS, Fromkes JJ, Ellison EC. Pancreatic tuberculosis. Am Surg 1995; 61:513.
  25. Gowrinath K, Ashok S, Thanasekaran V, Rao KR. Tuberculous cholecystitis. Int J Tuberc Lung Dis 1997; 1:484.
  26. Ramesh J, Banait GS, Ormerod LP. Abdominal tuberculosis in a district general hospital: a retrospective review of 86 cases. QJM 2008; 101:189.
  27. Sharma SK, Mohan A, Sharma A, Mitra DK. Miliary tuberculosis: new insights into an old disease. Lancet Infect Dis 2005; 5:415.
  28. Hussain W, Mutimer D, Harrison R, et al. Fulminant hepatic failure caused by tuberculosis. Gut 1995; 36:792.
  29. Slavin RE, Walsh TJ, Pollack AD. Late generalized tuberculosis: a clinical pathologic analysis and comparison of 100 cases in the preantibiotic and antibiotic eras. Medicine (Baltimore) 1980; 59:352.
  30. Baker CA, Cartwright CP, Williams DN, et al. Early detection of central nervous system tuberculosis with the gen-probe nucleic Acid amplification assay: utility in an inner city hospital. Clin Infect Dis 2002; 35:339.
  31. Caws M, Wilson SM, Clough C, Drobniewski F. Role of IS6110-targeted PCR, culture, biochemical, clinical, and immunological criteria for diagnosis of tuberculous meningitis. J Clin Microbiol 2000; 38:3150.
  32. Brienze VM, Pereira FJ, Liso E, et al. Low sensitivity of polymerase chain reaction for diagnosis of tuberculous meningitis in southeastern Brazil. Rev Soc Bras Med Trop 2001; 34:389.
  33. Namavar Jahromi B, Parsanezhad ME, Ghane-Shirazi R. Female genital tuberculosis and infertility. Int J Gynaecol Obstet 2001; 75:269.
  34. Sharma JB, Roy KK, Pushparaj M, et al. Laparoscopic findings in female genital tuberculosis. Arch Gynecol Obstet 2008; 278:359.
  35. Lee IK, Yang WC, Liu JW. Scrotal tuberculosis in adult patients: a 10-year clinical experience. Am J Trop Med Hyg 2007; 77:714.
  36. Lam KY, Lo CY. A critical examination of adrenal tuberculosis and a 28-year autopsy experience of active tuberculosis. Clin Endocrinol (Oxf) 2001; 54:633.
  37. Barnes DJ, Naraqi S, Temu P, Turtle JR. Adrenal function in patients with active tuberculosis. Thorax 1989; 44:422.
  38. CHAPMAN CB, WHORTON CM. Acute generalized miliary tuberculosis in adults. N Engl J Med 1946; 235:239.
  39. Wallis PJ, Branfoot AC, Emerson PA. Sudden death due to myocardial tuberculosis. Thorax 1984; 39:155.
  40. Cope AP, Heber M, Wilkins EG. Valvular tuberculous endocarditis: a case report and review of the literature. J Infect 1990; 21:293.
  41. Reuter H, Burgess LJ, Doubell AF. Role of chest radiography in diagnosing patients with tuberculous pericarditis. Cardiovasc J S Afr 2005; 16:108.
  42. Rooney JJ, Crocco JA, Lyons HA. Tuberculous pericarditis. Ann Intern Med 1970; 72:73.
  43. Cegielski JP, Lwakatare J, Dukes CS, et al. Tuberculous pericarditis in Tanzanian patients with and without HIV infection. Tuber Lung Dis 1994; 75:429.
  44. Nardell EA, Fan D, Shepard JA, Mark EJ. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 22-2004. A 30-year-old woman with a pericardial effusion. N Engl J Med 2004; 351:279.
  45. Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation 2005; 112:3608.
  46. Felson B, Akers PV, Hall GS, et al. Mycotic tuberculous aneurysm of the thoracic aorta. JAMA 1977; 237:1104.
  47. Rietbroek RC, Dahlmans RP, Smedts F, et al. Tuberculosis cutis miliaris disseminata as a manifestation of miliary tuberculosis: literature review and report of a case of recurrent skin lesions. Rev Infect Dis 1991; 13:265.
  48. Daikos GL, Uttamchandani RB, Tuda C, et al. Disseminated miliary tuberculosis of the skin in patients with AIDS: report of four cases. Clin Infect Dis 1998; 27:205.
  49. Johnson AW, Mokuolu OA, Ogan O. Tuberculous laryngitis in a Nigerian child. Ann Trop Paediatr 1993; 13:91.
  50. Vomero E, Ratner SJ. Diagnosis of miliary tuberculosis by examination of middle ear discharge. Arch Otolaryngol Head Neck Surg 1988; 114:1029.
  51. Basgoz N, Swartz MN. Infections of the thyroid gland. In: The Thyroid: A Fundamental and Clinical Text, Braverman LE, Utiger RD (Eds), Lippincott-Raven, 1996.
  52. MILDER E, OXENHORN S, SCHLECKER A, et al. A case of miliary tuberculosis simulating acute blastic leukemia. JAMA 1961; 177:116.
  53. TWOMEY JJ, LEAVELL BS. LEUKEMOID REACTIONS TO TUBERCULOSIS. Arch Intern Med 1965; 116:21.
  54. Hunt BJ, Andrews V, Pettingale KW. The significance of pancytopenia in miliary tuberculosis. Postgrad Med J 1987; 63:801.
  55. Campo E, Condom E, Miro MJ, et al. Tuberculosis-associated hemophagocytic syndrome. A systemic process. Cancer 1986; 58:2640.
  56. Isaacs RD, Nicholson GI, Holdaway IM. Miliary tuberculosis with hypercalcaemia and raised vitamin D concentrations. Thorax 1987; 42:555.
  57. Felson B. A new look at pattern recognition of diffuse pulmonary disease. AJR Am J Roentgenol 1979; 133:183.
  58. Felson B. The roentgen diagnosis of disseminated pulmonary alveolar diseases. Semin Roentgenol 1967; 2:3.
  59. Kwong JS, Carignan S, Kang EY, et al. Miliary tuberculosis. Diagnostic accuracy of chest radiography. Chest 1996; 110:339.
  60. Optican RJ, Ost A, Ravin CE. High-resolution computed tomography in the diagnosis of miliary tuberculosis. Chest 1992; 102:941.
  61. Voloudaki AE, Tritou IN, Magkanas EG, et al. HRCT in miliary lung disease. Acta Radiol 1999; 40:451.
  62. Lee KS, Kim TS, Han J, et al. Diffuse micronodular lung disease: HRCT and pathologic findings. J Comput Assist Tomogr 1999; 23:99.
  63. Lee J, Lim JK, Seo H, et al. Clinical relevance of ground glass opacity in 105 patients with miliary tuberculosis. Respir Med 2014; 108:924.
  64. Kao CH, Wang SJ, Liao SQ, et al. Usefulness of gallium-67-citrate scans in patients with acute disseminated tuberculosis and comparison with chest x-rays. J Nucl Med 1993; 34:1918.
  65. Brauner M, Buffard MD, Jeantils V, et al. Sonography and computed tomography of macroscopic tuberculosis of the liver. J Clin Ultrasound 1989; 17:563.
  66. Shinnick TM, Good RC. Diagnostic mycobacteriology laboratory practices. Clin Infect Dis 1995; 21:291.
  67. Hanna BA, Walters SB, Bonk SJ, Tick LJ. Recovery of mycobacteria from blood in mycobacteria growth indicator tube and Lowenstein-Jensen slant after lysis-centrifugation. J Clin Microbiol 1995; 33:3315.
  68. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000; 161:1376.
  69. Munseri PJ, Talbot EA, Bakari M, et al. The bacteraemia of disseminated tuberculosis among HIV-infected patients with prolonged fever in Tanzania. Scand J Infect Dis 2011; 43:696.
  70. Steingart KR, Henry M, Laal S, et al. A systematic review of commercial serological antibody detection tests for the diagnosis of extrapulmonary tuberculosis. Thorax 2007; 62:911.
  71. Dowdy DW, Steingart KR, Pai M. Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis. PLoS Med 2011; 8:e1001074.
  72. Steingart KR, Flores LL, Dendukuri N, et al. Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis. PLoS Med 2011; 8:e1001062.
  73. http://whqlibdoc.who.int/publications/2011/9789241502054_eng.pdf (Accessed on October 11, 2011).
  74. Mert A, Bilir M, Tabak F, et al. Miliary tuberculosis: clinical manifestations, diagnosis and outcome in 38 adults. Respirology 2001; 6:217.
  75. Willcox PA, Potgieter PD, Bateman ED, Benatar SR. Rapid diagnosis of sputum negative miliary tuberculosis using the flexible fibreoptic bronchoscope. Thorax 1986; 41:681.
  76. Pant K, Chawla R, Mann PS, Jaggi OP. Fiberbronchoscopy in smear-negative miliary tuberculosis. Chest 1989; 95:1151.
  77. Strumpf IJ, Tsang AY, Sayre JW. Re-evaluation of sputum staining for the diagnosis of pulmonary tuberculosis. Am Rev Respir Dis 1979; 119:599.
  78. Stender H, Mollerup TA, Lund K, et al. Direct detection and identification of Mycobacterium tuberculosis in smear-positive sputum samples by fluorescence in situ hybridization (FISH) using peptide nucleic acid (PNA) probes. Int J Tuberc Lung Dis 1999; 3:830.
  79. Roggenkamp A, Hornef MW, Masch A, et al. Comparison of MB/BacT and BACTEC 460 TB systems for recovery of mycobacteria in a routine diagnostic laboratory. J Clin Microbiol 1999; 37:3711.
  80. Crump JA, Ramadhani HO, Morrissey AB, et al. Bacteremic disseminated tuberculosis in sub-saharan Africa: a prospective cohort study. Clin Infect Dis 2012; 55:242.
  81. Pathology of Tuberculosis. The Internet Pathology Laboratory for Medical Education. Available at: http://www-medlib.med.utah.edu/WebPath/TUTORIAL/MTB/MTB.html (Accessed on March 23, 2006).
  82. Shinnick TM, Jonas V. Molecular approaches to the diagnosis of tuberculosis. In: Tuberculosis: pathogenesis, protection and control, Bloom BR (Ed), American Society of Microbiology Press, Washington DC 1994. p.517.
  83. Clarridge JE 3rd, Shawar RM, Shinnick TM, Plikaytis BB. Large-scale use of polymerase chain reaction for detection of Mycobacterium tuberculosis in a routine mycobacteriology laboratory. J Clin Microbiol 1993; 31:2049.
  84. Kaneko K, Onodera O, Miyatake T, Tsuji S. Rapid diagnosis of tuberculous meningitis by polymerase chain reaction (PCR). Neurology 1990; 40:1617.
  85. Akcan Y, Tuncer S, Hayran M, et al. PCR on disseminated tuberculosis in bone marrow and liver biopsy specimens: correlation to histopathological and clinical diagnosis. Scand J Infect Dis 1997; 29:271.
  86. Folgueira L, Delgado R, Palenque E, et al. Rapid diagnosis of Mycobacterium tuberculosis bacteremia by PCR. J Clin Microbiol 1996; 34:512.
  87. Schluger NW, Rom WN. The polymerase chain reaction in the diagnosis and evaluation of pulmonary infections. Am J Respir Crit Care Med 1995; 152:11.
  88. Aceti A, Zanetti S, Mura MS, et al. Identification of HIV patients with active pulmonary tuberculosis using urine based polymerase chain reaction assay. Thorax 1999; 54:145.
  89. Kaplan JE, Benson C, Holmes KK, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58:1.
  90. Havlir DV, Barnes PF. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1999; 340:367.
  91. Centers for Disease Control and Prevention (CDC). Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine--United States, 1997-2006. MMWR Morb Mortal Wkly Rep 2009; 58:1.
  92. Vadwai V, Boehme C, Nabeta P, et al. Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis? J Clin Microbiol 2011; 49:2540.
  93. Tortoli E, Russo C, Piersimoni C, et al. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J 2012; 40:442.
  94. American Thoracic Society. Medical Section of the American Lung Association: Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis 1986; 134:355.
  95. Oktay MF, Topcu I, Senyigit A, et al. Follow-up results in tuberculous cervical lymphadenitis. J Laryngol Otol 2006; 120:129.
  96. Dooley DP, Carpenter JL, Rademacher S. Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature. Clin Infect Dis 1997; 25:872.
  97. Centers for Disease Control and Prevention (CDC), American Thoracic Society. Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection--United States, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:735.
  98. FALK A. U. S. VETERANS ADMINISTRATION-ARMED FORCES COOPERATIVE STUDY ON THE CHEMOTHERAPY OF TUBERCULOSIS.13. TUBERCULOUS MENINGITIS IN ADULTS, WITH SPECIAL REFERENCE TO SURVIVAL, NEUROLOGIC RESIDUALS, AND WORK STATUS. Am Rev Respir Dis 1965; 91:823.
  99. Sahn SA, Neff TA. Miliary tuberculosis. Am J Med 1974; 56:494.
  100. Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994; 271:698.